Andropause: A Misnomer for a True Clinical Entity

The document discussed the condition known as androgen decline in the aging male (ADAM), which was often misnamed as male menopause or andropause. ADAM was characterized by a decrease in serum androgen and other hormones like growth hormone, melatonin, and dehydroepiandrosterone, leading to symptoms such as fatigue, depression, decreased libido, erectile dysfunction, and cognitive changes. The study emphasized the importance of recognizing and treating ADAM, especially in men over 50, and provided recommendations for its diagnosis, treatment, and monitoring. The research involved a comprehensive review of relevant literature and conference proceedings.